Evaluation of Socioeconomic and Racial/Ethnic Disparities in All-Cause Mortality in Adolescents and Young Adults With Cancer

Authors:
Scott Henderson Office of Research and Scholarship, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA

Search for other papers by Scott Henderson in
Current site
Google Scholar
PubMed
Close
 BS
,
Mark Duggan Office of Research and Scholarship, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA

Search for other papers by Mark Duggan in
Current site
Google Scholar
PubMed
Close
 MA
,
Chun Chao Department of Research and Evaluation, Kaiser Permanente Southern California, Southern California Permanente Medical Group, Pasadena, CA
Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA

Search for other papers by Chun Chao in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Robert Cooper Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA
Department of Pediatric Hematology/Oncology, Los Angeles Medical Center, Southern California Permanente Medical Group, Los Angeles, CA

Search for other papers by Robert Cooper in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access

Background: Adolescent and young adult (AYA) patients with cancer have historically been understudied. Few studies have examined survival disparities associated with racial/ethnic and socioeconomic status (SES) and do not account for the influence of insurance status and access to care. We evaluated the association of SES and race/ethnicity with overall mortality for AYA patients who were members of an integrated health system with relatively equal access to care. Methods: AYA patients diagnosed with the 15 most common cancer types during 2010 through 2018 at Kaiser Permanente Southern California were included. Neighborhood Deprivation Index (NDI) quartile (Q1: least deprived; Q4: most deprived) was used as a measure of SES. Mortality rate per 1,000 person-years was calculated for each racial/ethnic and NDI subgroup. Multivariable Cox model was used to estimate hazard ratios (HRs) for all-cause mortality adjusting for sex, age and stage at diagnosis, cancer type, race/ethnicity, and NDI. Results: Data for 6,379 patients were tracked for a maximum of 10 years. Crude mortality rates were higher among non-White racial/ethnic patients compared with non-Hispanic (NH)–White patients. In the Cox model, Hispanic (HR, 1.31; P=.004) and NH-Black (HR, 1.34; P=.05) patients experienced significantly higher all-cause mortality risk compared with NH-White patients. Patients from more deprived neighborhoods had higher mortality risk. In the Cox model, there was no significant difference in all-cause mortality between Q1 and Q2 through Q4 (Q2: HR, 0.88; P=.26, Q3: HR, 0.94; P=.56, and Q4: HR, 0.95; P=.70). Conclusions: For AYAs with cancer with similar access to care, Hispanic and NH-Black patients have higher risk of all-cause mortality than NH-White patients, whereas no significant SES-associated survival disparities were observed. These findings warrant further investigation, awareness, and intervention to address inequities in cancer care among vulnerable populations.

Submitted September 5, 2023; final revision received February 29, 2024; accepted for publication March 19, 2024.

Author contributions: Study design: Henderson, Chao, Cooper. Investigation: Duggan. Writing—original draft: Henderson. Writing—review & editing: Duggan, Chao, Cooper.

Disclosures: The authors have disclosed that they have not received any financial consideration from any person or organization to support the preparation, analysis, results, or discussion of this article.

Funding: Research reported in this publication was supported by the Regional Research Committee Kaiser Permanente Southern California (KP-RRC-20191004; R. Cooper).

Correspondence: Scott Henderson, BS, Kaiser Permanente Bernard J. Tyson School of Medicine, 98 South Los Robles Avenue, Pasadena, CA 90029. Email: scott.henderson@mountsinai.org
  • Collapse
  • Expand
  • 1.

    US National Cancer Institute. Adolescents and young adults with cancer. Accessed January 5, 2024. Available at: https://www.cancer.gov/types/aya

  • 2.

    Overholser L, Kilbourn K, Liu A. Survivorship issues in AYA oncology. Med Clin North Am 2017;101:10751084.

  • 3.

    Burkart M, Sanford S, Dinner S, et al. Future health of AYA survivors. Pediatr Blood Cancer 2019;66:e27516.

  • 4.

    Murphy CC, Lupo PJ, Roth ME, et al. Disparities in cancer survival among adolescents and young adults: a population-based study of 88,000 patients. J Natl Cancer Inst 2021;113:10741083.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 2010;28:26252634.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Keegan TH, Lichtensztajn DY, Kato I, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv 2012;6:239250.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Cooper RM, Chung J, Hogan T, et al. Patterns of overall mortality by race/ethnicity and socioeconomic status in insured cancer patients in Southern California. Cancer Causes Control 2021;32:609616.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Smedley BD, Stith AY, Nelson AR, et al. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. National Academies Press; 2003.

  • 9.

    Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004;54:7893.

  • 10.

    Velasco-Mondragon E, Jimenez A, Palladino-Davis AG, et al. Hispanic health in the USA: a scoping review of the literature. Public Health Rev 2016;37:31.

  • 11.

    Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: over six decades of changing patterns and widening inequalities. J Environ Public Health 2017;2017:2819372.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Chao C, Bhatia S, Xu L, et al. Chronic comorbidities among survivors of adolescent and young adult cancer. J Clin Oncol 2020;38:31613174.

  • 13.

    Parsons HM, Harlan LC, Seibel NL, et al. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol 2011;20;29:40454053.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Moke DJ, Tsai K, Hamilton AS, et al. Emerging cancer survival trends, disparities, and priorities in adolescents and young adults: a California Cancer Registry-based study. JNCI Cancer Spectr 2019;3:pkz031.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Alvarez EM, Keegan THM, Johnston EE, et al. Adolescent and young adult (AYA) oncology patients: disparities in access to specialized cancer centers. J Clin Oncol 2016;123(Suppl):Abstract e18020.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Smits-Seemann RR, Kaul S, Zamora ER, et al. Barriers to follow-up care among survivors of adolescent and young adult cancer. J Cancer Surviv 2017;11:126132.

  • 17.

    Coker Appiah L, Fei YF, Olsen M, et al. Disparities in female pediatric, adolescent and young adult oncofertility: a needs assessment. Cancers (Basel) 2021;13:5419.

  • 18.

    Siembida EJ, Loomans-Kropp HA, Trivedi N, et al. Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: identifying opportunities for intervention. Cancer 2020;126:949957.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Muffly L, Yin J, Jacobson S, et al. Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia. Blood Adv 2022;6:40854092.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Mittal N, Saha A, Avutu V, et al. Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials. Sci Rep 2022;12:3875.

  • 21.

    DeRouen MC, Parsons HM, Kent EE, et al. Sociodemographic disparities in survival for AYAs with cancer differ by health insurance status. Cancer Causes Control 2017;28:841851.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Tehranifar P, Neugut AI, Phelan JC, et al. Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev 2009;18:27012708.

  • 23.

    Keegan THM, DeRouen MC, Parsons HM, et al. Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: a population-based study. Cancer Epidemiol Biomarkers Prev 2016;25:264273.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Chao C, Chiu V, Xu L, et al. Survival differences by race/ethnicity and neighborhood socioeconomic status in adolescents and young adults diagnosed with non-Hodgkin lymphoma. J Adolesc Young Adult Oncol 2015;4:7683.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Bownes LV, Stafman LL, Maizlin II, et al. Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population. J Surg Res 2018;222:180186.e3.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Cuglievan B, Berkman A, Dibaj S, et al. Impact of lagtime, health insurance type, and income status at diagnosis on the long-term survival of adolescent and young adult cancer patients. J Adolesc Young Adult Oncol 2021;10:164174.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Call KT, McAlpine DD, Garcia CM, et al. Barriers to care in an ethnically diverse publicly insured population: is health care reform enough? Med Care 2014;52:720727.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Zhu J, Brawarsky P, Lipsitz S, et al. Massachusetts health reform and disparities in coverage, access and health status. J Gen Intern Med 2010;25:13561362.

  • 29.

    DeNavas-Walt C, Proctor BD, Smith JC. Income, poverty, and health insurance coverage in the United States: 2007. Accessed January 5, 2024. Available at: https://www.census.gov/library/publications/2008/demo/p60-235.html

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Messer LC, Laraia BA, Kaufman JS, et al. The development of a standardized neighborhood deprivation index. J Urban Health 2006;83:10411062.

  • 31.

    Richter D, Mehnert A, Forstmeyer D, et al. Health literacy in adolescent and young adult cancer patients and its association with health outcomes. J Adolesc Young Adult Oncol 2019;8:451457.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Prussien KV, Barakat LP, Darabos K, et al. Sociodemographics, health competence, and transition readiness among adolescent/young adult cancer survivors. J Pediatr Psychol 2022;47:10961106.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Kaul S, Avila JC, Mehta HB, et al. Cost-related medication nonadherence among adolescent and young adult cancer survivors. Cancer 2017; 123:27262734.

    • PubMed
    • Export Citation
  • 34.

    Kirchhoff AC, Lyles CR, Fluchel M, et al. Limitations in health care access and utilization among long-term survivors of adolescent and young adult cancer. Cancer 2012;118:59645972.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Meernik C, Dorfman CS, Zullig LL, et al. Health care access barriers and self-reported health among adolescent and young adult cancer survivors. J Adolesc Young Adult Oncol 2024;13:112122.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Freyer DR, Brugieres L. Adolescent and young adult oncology: transition of care. Pediatr Blood Cancer 2008;50(5 Suppl):11161119.

  • 37.

    Smitherman AB, Anderson C, Lund JL, et al. Frailty and comorbidities among survivors of adolescent and young adult cancer: a cross-sectional examination of a hospital-based survivorship cohort. J Adolesc Young Adult Oncol 2018;7:374383.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Lazow MA, Salloum R, Pressey JG. Comorbidity burden in a cohort of adolescent and young adult patients diagnosed with central nervous system tumors and sarcomas. J Adolesc Young Adult Oncol 2023;12:215223.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Cheung CK, Tucker-Seeley R, Davies S, et al. A call to action: antiracist patient engagement in adolescent and young adult oncology research and advocacy. Future Oncol 2021;17:37433756.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Scott AR, Stoltzfus KC, Tchelebi LT, et al. Trends in cancer incidence in US adolescents and young adults, 1973–2015. JAMA Netw Open 2020;3:e2027738.

  • 41.

    Chao C, Chiu V, Mueller LA, et al. Exploring the feasibility of establishing a retrospective cohort of survivors of adolescent and young adult cancer to study long-term health outcomes in an integrated managed care environment. J Adolesc Young Adult Oncol 2013;2:5965.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42.

    Armenian SH, Xu L, Cannavale KL, et al. Cause-specific mortality in survivors of adolescent and young adult cancer. Cancer 2020;126:23052316.

  • 43.

    Beauchemin MP, Roth ME, Parsons SK. Reducing adolescent and young adult cancer outcome disparities through optimized care delivery: a blueprint from the Children’s Oncology Group. J Adolesc Young Adult Oncol 2023;12:314323.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 127 127 127
PDF Downloads 80 80 80
EPUB Downloads 0 0 0